Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Caribou Biosciences (CRBU) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Caribou Biosciences (CRBU) over the last 5 years, with Q3 2025 value amounting to 0.88%.

  • Caribou Biosciences' Return on Capital Employed fell 3800.0% to 0.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88%, marking a year-over-year decrease of 3800.0%. This contributed to the annual value of 0.49% for FY2024, which is 1800.0% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Return on Capital Employed is 0.88%, which was down 3800.0% from 0.77% recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Return on Capital Employed peaked at 0.16% during Q4 2021, and registered a low of 0.88% during Q3 2025.
  • For the 5-year period, Caribou Biosciences' Return on Capital Employed averaged around 0.39%, with its median value being 0.34% (2024).
  • As far as peak fluctuations go, Caribou Biosciences' Return on Capital Employed surged by 200bps in 2023, and later tumbled by -3800bps in 2025.
  • Over the past 5 years, Caribou Biosciences' Return on Capital Employed (Quarter) stood at 0.16% in 2021, then plummeted by -86bps to 0.3% in 2022, then grew by 6bps to 0.28% in 2023, then tumbled by -101bps to 0.56% in 2024, then tumbled by -58bps to 0.88% in 2025.
  • Its last three reported values are 0.88% in Q3 2025, 0.77% for Q2 2025, and 0.62% during Q1 2025.